News from the College

  • Kolb Receives NCI Grant to Develop Treatment for Chemo-Induced Nerve Damage
    September 21, 2021
    The National Cancer Institute (NCI) has awarded Noah Kolb, M.D., associate professor of neurological sciences at the University of Vermont's Larner College Medicine, and a team of researchers a $7 million grant to a develop a new intervention for chemo-induced neuropathy, one that can be as easily implemented in rural areas as large urban centers.
  • UVM Undergrad Alums Launch VT REACH for Pre-Health Career Students
    September 21, 2021
    VT REACH, which stands for Virtual Teleconference: Reach Explore Aspire to Careers in Healthcare, is an outreach program designed for high school, college, technical school, undecided students who are interested in potentially pursuing careers in healthcare and provides an opportunity to learn from and interact with professionals and students from the Larner College of Medicine and UVM Medical Center.
  • Med Student-Designed "Look at Larner" Program Holds First Event
    September 21, 2021
    On September 10 and 11, the Larner College of Medicine welcomed 27 individuals from across the country as participants in the first-ever “Look at Larner” program. Candidates in the program were aspiring medical students, from rising college juniors to postgraduates and career changers.
  • Raszka Receives AOA/AAMC Glaser Distinguished Teacher Award
    August 26, 2021
    Professor of Pediatrics William Raszka, M.D., has received the prestigious 2021 Alpha Omega Alpha Robert J. Glaser Distinguished Teacher Award. The award is part of the Association of American Medical Colleges annual slate of honors and will be formally conferred at an October 27 virtual recognition event.
  • Camp Outright Elective Connects Medical Trainees and LGBTQ+ Youth
    August 25, 2021
    Described as “a traditional summer camp experience with a queer twist,” Camp Outright provides a supportive environment and a range of activities focused on community, social justice, and fun for youth aged 13 to 17. During the two 2021 summer sessions, the camp also served as a place for medical trainees and campers to see a different side of patient care and clinicians, respectively.
  • King’s Leadership Ushers in Changes to Medical Board Policies on Sexual Misconduct
    August 11, 2021
    Patricia King, M.D., Ph.D., UVM professor of medicine and former chair of the Federation of State Medical Boards (FSMB), led and created the Workgroup on Physician Sexual Misconduct, which conducted a deep review of all available U.S. sexual misconduct disciplinary data, and state medical board physician sexual misconduct laws, policies and procedures might be contributing to this dire problem. Their findings were reported in 2020 and featured in an April 27, 2021 JAMA Viewpoint article.
  • Heil's Study Tests Co-location of Contraceptive Services with Opioid Treatment Programs
    August 4, 2021
    More than 75% of women with Opioid Use Disorder report having had an unintended pregnancy, but they are less likely to use effective contraception compared to women who do not use drugs. Results from a multi-year trial led by UVM Professor Sarah Heil found that a two-part intervention featuring co-located contraceptive services in opioid treatment programs and financial incentives could offer an effective solution.
  • Hearts & Brains: UVM’s Newest COBRE Hits Its Stride at One-Year Anniversary
    July 22, 2021
    Not only is Vermont small and rural, but it’s also old. Currently, the state is ranked fourth in the nation for the relative number of residents over 65 years old – a whopping nearly 20 percent of Vermont’s population and rising. And with that status comes a disproportionately large share of heart disease, as well as blood vessel diseases and brain circulation problems that can lead to dementia and Alzheimer’s disease.
  • Research Team Uncovers Unexplored Universe of Calcium Signals in the Brain
    July 21, 2021
    UVM and University of Maryland researchers have shown how the brain communicates to blood vessels when in need of energy, and how these blood vessels respond to direct blood flow to specific brain regions -- information that can help determine what goes wrong in conditions like Alzheimer’s disease and dementia, where faulty blood flow is a predictor for cognitive impairment.
  • Cushman & Colleagues' Study Shows Benefits of Early Anticlotting Therapy in Moderate COVID-19
    July 13, 2021
    New trial results from the University of Vermont and an international team of researchers show that administering a full dose of a standard blood thinner early to moderately ill hospitalized patients with COVID-19 could reduce the risk of severe disease and death.